Colzyx is led by a highly qualified, interdisciplinary team with broad experience in life science and research successes published in peer-reviewed journals. Along
with the proven track record in bioscience research, our team is highly skilled in business development and project management.

Dr Karin Bryder,
CEO, co-founder

Karin has a vast experience from startup companies in life sciences. Her work spans from research and method development of vaccines and virus diagnostics through protein pharmaceuticals, small molecule development and patent portfolio management. Karin has in the last few years worked extensively with medical device development as project manager and CEO. Karin is a co- founder of Colzyx and the CEO of Colzyx.

Dr Matthias Mörgelin,
CSO, co-founder

Matthias is the key inventor to Colzyx’ patent applications and has discovered the unique properties of human collagen VI. Matthias holds a PhD in Natural Sciences from Basel University and has more than 30 years of academic experience in life science. Matthias is a founder of Colzyx and the CTO of Colzyx.

Dr Eskil Söderlind,

Eskil has more than 25 years of business experience in life sciences and has been instrumental in the incorporation of more than 10 different companies. Eskil has an established network of contacts in the MedTech industry crucial for the project. Eskil has a PhD in molecular biology from Uppsala and holds an MBA-diploma. Eskil is a co-founder of Colzyx and acts as the chairperson of the board.

Ulrika Andersson
Director Quality and Regulatory Management

Ulrika is well experienced within the field of quality and regulatory management for medical devices, from design and development to commercialisation. She has built several Quality Management Systems and managed registration of products in the EU and US. She has a BSc in Chemical Engineering from Lund´s Faculty of Engineering (LTH). Ulrika is Director Quality and Regulatory Management of Colzyx.